AI-Driven Structural Analysis Clarifies Novel TNFRSF17 Variants of Uncertain Significance as Candidate Resistance Mechanisms to BCMA-Targeted Immunotherapies in Multiple Myeloma

Ricardo Ahrens, Behnam Yousefi, Nora Constanze Laubach, Marietta Truger, Torsten Haferlach, Sven Heins, Raphael Teipel, Constantine Mitsiades, Evangelos Papadopoulos, Kyra Ahrens, Piet Sonnemann, Maximilian Al-Bazaz, Jule Artzenroth, Lisa Leypoldt, Christoph Schaefers, Maximilian Christopeit, Moritz Kaune, Leo Rasche, Carsten Bokemeyer, Stefan Bonn, Katja Weisel, Winfried Alsdorf

Open source

DOI: 10.1016/j.clml.2026.09.010
Published: 2026-09
Container: Clinical Lymphoma Myeloma and Leukemia
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.clml.2026.09.010,
  title = {AI-Driven Structural Analysis Clarifies Novel TNFRSF17 Variants of Uncertain Significance as Candidate Resistance Mechanisms to BCMA-Targeted Immunotherapies in Multiple Myeloma},
  author = {Ricardo Ahrens and Behnam Yousefi and Nora Constanze Laubach and Marietta Truger and Torsten Haferlach and Sven Heins and Raphael Teipel and Constantine Mitsiades and Evangelos Papadopoulos and Kyra Ahrens and Piet Sonnemann and Maximilian Al-Bazaz and Jule Artzenroth and Lisa Leypoldt and Christoph Schaefers and Maximilian Christopeit and Moritz Kaune and Leo Rasche and Carsten Bokemeyer and Stefan Bonn and Katja Weisel and Winfried Alsdorf},
  year = {2026},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  doi = {10.1016/j.clml.2026.09.010},
  url = {https://doi.org/10.1016/j.clml.2026.09.010}
}

RIS

TY  - JOUR
TI  - AI-Driven Structural Analysis Clarifies Novel TNFRSF17 Variants of Uncertain Significance as Candidate Resistance Mechanisms to BCMA-Targeted Immunotherapies in Multiple Myeloma
AU  - Ricardo Ahrens
AU  - Behnam Yousefi
AU  - Nora Constanze Laubach
AU  - Marietta Truger
AU  - Torsten Haferlach
AU  - Sven Heins
AU  - Raphael Teipel
AU  - Constantine Mitsiades
AU  - Evangelos Papadopoulos
AU  - Kyra Ahrens
AU  - Piet Sonnemann
AU  - Maximilian Al-Bazaz
AU  - Jule Artzenroth
AU  - Lisa Leypoldt
AU  - Christoph Schaefers
AU  - Maximilian Christopeit
AU  - Moritz Kaune
AU  - Leo Rasche
AU  - Carsten Bokemeyer
AU  - Stefan Bonn
AU  - Katja Weisel
AU  - Winfried Alsdorf
PY  - 2026
JO  - Clinical Lymphoma Myeloma and Leukemia
DO  - 10.1016/j.clml.2026.09.010
UR  - https://doi.org/10.1016/j.clml.2026.09.010
ER  -

APA

Ahrens, R., Yousefi, B., Laubach, N. C., Truger, M., Haferlach, T., Heins, S., Teipel, R., Mitsiades, C., Papadopoulos, E., Ahrens, K., Sonnemann, P., Al-Bazaz, M., Artzenroth, J., Leypoldt, L., Schaefers, C., Christopeit, M., Kaune, M., Rasche, L., Bokemeyer, C., Bonn, S., Weisel, K., & Alsdorf, W. (2026). AI-Driven Structural Analysis Clarifies Novel TNFRSF17 Variants of Uncertain Significance as Candidate Resistance Mechanisms to BCMA-Targeted Immunotherapies in Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2026.09.010

Source records

crossref · retrieved 2026-11-07T02:08:29.198Z